Dr. Vijendra Swarup

Dr. Swarup is specially trained in performing complex trans-catheter ablations. He has special interest in electro – anatomical and 3 Dimensional Electroanatomical mapping techniques, left atrial appendage occlusion techniques and ablative therapies for atrial fibrillation and ventricular tachycardia.In Arizona, Dr. Swarup was among the first to perform epicardial and endocardial 3D mapping guided ablation of ischemic ventricular tachycardias, open irrigated ablations, Robotic catheter ablations for arrhythmias and implantation to left atrial appendage occlusion devices. Dr. Swarup has one of the largest experience in AF and VT ablations and implantation of LAA occlusion devices in the country. Dr. Swarup is also an active researcher of new ablation techniques, having authored numerous abstracts and manuscripts. He has been the principal investigator in many research protocols investigating promising new ablation techniques and devices for treatment of arrhythmias.At the Arizona Heart Rhythm Center, we are a dedicated team of professionals treating heart rhythm abnormalities. We treat each patient as an individual with specific needs and emotional responses to his or her symptoms and concerns. We think of our patients as partners in the task of restoring them to good health. In this mutual enterprise, communication, education and full disclosure are key elements for both partners.  Our entire staff partner with patients and their families to identify a full range of patient needs and desires. Your well-being and highest possible quality of life are our top priorities.

Dr. Swarup is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Arrhythmias, Sick Sinus Syndrome, Cardiac Ablation, and Pacemaker Implantation.

Dr. Swarup is board certified in Internal Medicine (Sub: Clin Cardiac Electrophysiolog and Internal Medicine (Sub: Cardiovascular Disease). He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 16 clinical trials.